Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads

Published:2020-09 Issue:9 Volume:16 Page:1237-1247
ISSN:1551-7411
Container-title:Research in Social and Administrative Pharmacy
language:en
Short-container-title:Research in Social and Administrative Pharmacy

Author:

Aikin Kathryn J.,Betts Kevin R.,Boudewyns Vanessa,Johnson Mihaela,Davis Christine N.

Funder

Center for Drug Evaluation and Research

Food and Drug Administration

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacy

Reference38 articles.

1. FDA Prescription Drug Advertising, 21 C.F.R. 202.1,2018

2. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising;Frosch;Am J Public Health,2010

3. Serious and actionable risks, plus disclosure: investigating an alternative approach for presenting risk information in prescription drug television advertisements;Betts;Res Soc Adm Pharm,2018

4. Risk perception and communication;Fischhoff,2013

5. Cognitive load theory and the format of instruction;Chandler;Cognit InStruct,1991

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A scoping review of empirical research on prescription drug promotion;Research in Social and Administrative Pharmacy;2023-06

2. Qualitative Analysis of Patient–Physician Discussions Regarding Anticoagulation for Atrial Fibrillation;JAMA Internal Medicine;2022-12-01

3. The impact of interactive advertising on consumer engagement, recall, and understanding: A scoping systematic review for informing regulatory science;PLOS ONE;2022-02-03

4. Consumer Advertising and Health Communication;The Routledge Handbook of Health Communication;2021-08-26

5. The FDA’s Diverse and Dynamic Activities in the Social and Behavioral Sciences: Advancing and Supporting Health Equity;Journal of Primary Care & Community Health;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3